Fundraising Fox

Angarus Therapeutics

Portola Valley, US · Founded 2018 · Delaware corporation

Angarus Therapeutics was a biotechnology company. It is no longer operating.

Founders & leadership

CL
Chih-Ping LiuNamed on SEC filing
NR
Nigel RayNamed on SEC filing
PL
Peter LangeckerNamed on SEC filing
JL
Jean LiuNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$11.3M disclosed across 1 round · 2020

$11.3MraisedJul 2021 · 81 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chih-Ping LiuDirector
  • Nigel RayExecutive Officer, Director
  • Peter LangeckerDirector
  • Jean LiuDirector
Offering amount
$11.3M
Amount sold
$11.3M
Sales commissions
$468.4K
Placement agents
CIM SECURITIES, LLC
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Angarus Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Angarus Therapeutics do?
Angarus Therapeutics was a biotechnology company. It is no longer operating.
How much funding has Angarus Therapeutics raised?
Angarus Therapeutics has disclosed $11.3M raised across 1 round.
Where is Angarus Therapeutics headquartered?
Angarus Therapeutics is headquartered in Portola Valley, US.